These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25942044)

  • 21. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
    Gibbons RD; Brown CH; Hur K; Davis J; Mann JJ
    Arch Gen Psychiatry; 2012 Jun; 69(6):580-7. PubMed ID: 22309973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system.
    Zeni AL; Zomkowski AD; Maraschin M; Rodrigues AL; Tasca CI
    Eur J Pharmacol; 2012 Mar; 679(1-3):68-74. PubMed ID: 22266492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.
    Wong EH; Sonders MS; Amara SG; Tinholt PM; Piercey MF; Hoffmann WP; Hyslop DK; Franklin S; Porsolt RD; Bonsignori A; Carfagna N; McArthur RA
    Biol Psychiatry; 2000 May; 47(9):818-29. PubMed ID: 10812041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.
    Talbot JN; Jutkiewicz EM; Graves SM; Clemans CF; Nicol MR; Mortensen RM; Huang X; Neubig RR; Traynor JR
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11086-91. PubMed ID: 20534514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG
    J Affect Disord; 2009 Apr; 114(1-3):143-8. PubMed ID: 18692250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour.
    O'Leary A; Kõiv K; Raudkivi K; Harro J
    Pharmacol Res; 2016 Nov; 113(Pt B):739-746. PubMed ID: 26920253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.
    Scorza MC; Lladó-Pelfort L; Oller S; Cortés R; Puigdemont D; Portella MJ; Pérez-Egea R; Alvarez E; Celada P; Pérez V; Artigas F
    Br J Pharmacol; 2012 Nov; 167(5):1021-34. PubMed ID: 22050051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J; Sarkar J; Hiegel C; Uphouse L
    Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for intact 5-HT
    Babb JA; Linnros SE; Commons KG
    Neuropharmacology; 2018 Oct; 141():139-147. PubMed ID: 30170082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB; Nielsen EØ; Mirza NR
    Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test.
    Szewczyk B; Poleszak E; Wlaź P; Wróbel A; Blicharska E; Cichy A; Dybała M; Siwek A; Pomierny-Chamioło L; Piotrowska A; Brański P; Pilc A; Nowak G
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):323-9. PubMed ID: 19150479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressants and suicide attempts in children.
    Cooper WO; Callahan ST; Shintani A; Fuchs DC; Shelton RC; Dudley JA; Graves AJ; Ray WA
    Pediatrics; 2014 Feb; 133(2):204-10. PubMed ID: 24394688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
    Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
    Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
    Eker SS; Kirli S; Akkaya C; Cangur S; Sarandol A
    World J Biol Psychiatry; 2009; 10(4 Pt 2):400-8. PubMed ID: 19670086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
    Takahashi E; Katayama M; Niimi K; Itakura C
    Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy of major depressive disorder in adolescents.
    Masi G; Liboni F; Brovedani P
    Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.